First Wave

United States · Founded 2014

Headquarters
Florida
Founded
2014
Business Model
B2B

About

First Wave BioPharma, Inc. (Nasdaq: FWBI) is a clinical-stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for gastrointestinal diseases. The company's pipeline includes adrulipase, a Phase II-stage treatment, along with additional unlicensed GI-focused assets. In 2024, First Wave BioPharma completed a business combination with ImmunogenX, adding Phase 3-ready latiglutenase (for celiac disease) to its late-stage GI-focused clinical pipeline. The combined company is focused on advancing multiple non-systemic GI therapeutics addressing significant unmet medical needs.

Summary

First Wave is a Biotech company based in United States, founded in 2014.

Similar Companies